Latest News : 2016 : November

The name change from Life Science and Technology Park to Converge Miami will be complete when new signage — shown here in an artist's depiction — is installed.

UM and Partners Push to Accelerate Technology Innovation in South Florida

When University of Miami President Julio Frenk delivered his inauguration speech on January 29, one of the ambitious ideas he put forth was “the development of a major innovation hub with hemispheric scope” — a challenge for which he said the University was uniquely positioned. Strengthened by a new partnership and directed by a new strategy, UM is setting off on the path to meet Frenk’s challenge.

Read more »

From left, Bart Roep, M.D., Ph.D., Camillo Ricordi, M.D., Laurence B. Gardner, M.D., MACP, Alberto Pugliese, M.D., President Julio Frenk, Joshua Rednik and Valentina Pugliese (seated).

Dr. Alberto Pugliese Celebrated as Inaugural Holder of the Dodson Chair in Diabetes Research

Alberto Pugliese, M.D., a world-renowned researcher in diabetes and immunogenetics at the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine, was presented with the J. Enloe and Eugenia J. Dodson Chair in Diabetes Research. Pugliese, professor of medicine, and microbiology and immunology, and Deputy Director for Immune Tolerance Research at the DRI, is the first holder of the chair.

Read more »

Camillo Ricordi, M.D.

Researchers Develop Procedure for Standardized Pancreatic Islet Cell Production at Multiple Sites

The Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine, in a collaborative study with seven other institutions around the world, has demonstrated the feasibility of large-scale production of pancreatic islet cells by multiple manufacturing sites using a standardized process. Their report was published as the cover story in the November issue of Diabetes.

Read more »